Clinical Trial Update: Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating combination chemotherapy with rituximab for newly diagnosed Burkitt's lymphoma or leukemia has completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkitt Leukemia
• Burkitt Lymphoma
• Leukemia
• Lymphoma

Drugs mentioned

• Chemotherapy (chemotherapy)
• Rituximab (rituximab)

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Leukemia, Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2018-09-17